Financials data is unavailable for this security.
Cash flow in EURView more
In 2023, Faron Pharmaceuticals Oy did not generate a significant amount of cash. Cash Flow from Financing totalled 23.98m or -- of revenues. In addition the company used 23.81m for operations while cash used for investing totalled 123.00k.
Cash flow per share | -0.3095 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0109 |
---|---|
Tangible book value per share | 0.0023 |
More ▼
Balance sheet in EURView more
Current ratio | 1.45 |
---|---|
Quick ratio | -- |
Total debt/total equity | 9.23 |
---|---|
Total debt/total capital | 0.9022 |
More ▼